Ginkgo Bioworks Holdings Total Revenue

Ginkgo Bioworks Holdings (DNA) currently reports a total revenue of $92M as of June 2026. That compares with $230M in the prior-year period — down 60.0% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Ginkgo Bioworks Holdings's total revenue history and peer comparisons.

Ginkgo Bioworks Holdings's total revenue decreased from $230M to $92M — a 60.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ginkgo Bioworks Holdings's total revenue of $92M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Ginkgo Bioworks Holdings reported $92M in total revenue as of June 2026. That compares with $230M in the prior-year period — down 60.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $92M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Ginkgo Bioworks Holdings, and consider following DNA for alerts when major investors trade the stock.